SNTI
Senti Biosciences, Inc.
NASDAQ · Healthcare · Biotechnology · US
$0.31
+0.58%Next report
Analyst consensus
- Next report date
- Nov 12, 2026
- EPS estimate
- -$0.21
- Revenue estimate
- $15.9K
Latest reported
- Last report date
- Aug 14, 2026
- EPS actual
- -$0.41
- EPS estimate
- -$0.33
- Revenue actual
- $17.0K
- Revenue estimate
- $17.0K
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 6
- EPS misses (12Q)
- 4
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- -15.7%
- Revenue beats (12Q)
- 3
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 14, 2026 | -$0.33 | -$0.41 | Miss -24.24% | $17.0K |
| May 14, 2026 | -$0.27 | -$0.36 | Miss -33.33% | $16.0K |
| Mar 27, 2026 | -$0.43 | -$0.38 | Beat 11.63% | $22.0K |
| Nov 13, 2025 | -$0.59 | -$0.69 | Miss -16.95% | — |
| Aug 7, 2025 | -$0.90 | -$0.56 | Beat 37.78% | — |
| Mar 20, 2025 | -$3.13 | -$0.67 | Beat 78.59% | $5.9M |
| Nov 14, 2024 | — | -$6.31 | — | — |
| May 9, 2024 | — | -$2.60 | — | — |
| Mar 21, 2024 | -$0.23 | -$4.20 | Miss -1726.09% | $333.0K |
| Nov 13, 2023 | -$4.80 | -$2.50 | Beat 47.92% | $255.0K |
| Aug 11, 2023 | -$4.80 | -$4.20 | Beat 12.50% | $937.0K |
| Mar 22, 2023 | -$4.70 | -$4.20 | Beat 10.64% | $59.0K |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 12, 2026